Altox

Database / API & reference standards

API & reference standards

Ponatinib

Ponatinib is listed in the API and reference-standard collection under CAS 943319-70-8. Its represented structure has formula C29H27F3N6O and a calculated molecular weight of 532.57 g/mol.

2D chemical structure

O N H N N F F F N N N

Chemical identity

Catalog name
Ponatinib
Common name
Ponatinib
Chemical name
3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide
CAS
943319-70-8
SMILES
Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12
InChI
InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39)
InChIKey
PHXJVRSECIGDHY-UHFFFAOYSA-N
Associated API
Ponatinib

Record ID: A2dcda60e2946

Computed properties

C29H27F3N6O Molecular formula
532.57 g/molMolecular weight
532.2198 DaMonoisotopic exact mass
65.77 ŲTopological polar surface area
4.456 Calculated LogP (Wildman–Crippen)
142.3172 cm³/molMolar refractivity (Wildman–Crippen)
5 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C F H N O 0 8 16 24 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight532.5787.96
Calculated LogP (Wildman–Crippen)4.45684.13
Topological polar surface area65.7746.03
Hydrogen-bond acceptors565.12
Hydrogen-bond donors138.08
Rotatable bonds (strict)449.39

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC29H27F3N6Odimensionless
Molecular weight532.57g/mol
Monoisotopic exact mass532.2198Da
Topological polar surface area65.77Ų
Calculated LogP (Wildman–Crippen)4.456dimensionless
Molar refractivity (Wildman–Crippen)142.3172cm³/mol
Hydrogen-bond acceptors5count
Hydrogen-bond donors1count
Rotatable bonds (strict)4count
Heavy atoms39count
Heteroatoms10count
Rings5count
Aromatic rings4count
Aliphatic rings1count
Saturated rings1count
Aromatic heterocycles2count
Aliphatic heterocycles1count
Saturated heterocycles1count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.2759fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area223.8069Ų
Valence electrons200count
Radical electrons0count
Bertz complexity1,575.4239index
Balaban J1.3494index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Ponatinib

PDE, HBEL and impurity assessment for Ponatinib

For a substance-specific assessment, request a PDE report for Ponatinib or explore HBEL derivation for Ponatinib. These services address exposure limits using toxicological evidence and the intended use of the substance.

For pharmaceutical development, explore prediction of degradation products of Ponatinib and qualification of impurities related to Ponatinib.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Ponatinib

Explore Altox services and software through the Altox Pharma-Hub.